Arcturus Therapeutics Stock Is 19% Down So Far On Tuesday
Arcturus Therapeutics, a San Diego-based firm committed to the development of clinical messenger RNA medicines and vaccines, is currently grappling with a noticeable downturn in the stock market. On Tuesday, the company’s shares fell by a staggering 19%, reflecting a broader bearish trend. This represents the latest in a string of losses for the biotechnology…